Skip to main content
. 2015 Aug 7;10(8):e0135145. doi: 10.1371/journal.pone.0135145

Table 4. Joint effects of TG-related risk alleles on TG level and the risk for a high TG level (≥ 150 mg/dl) in T2D patients.

Quartile TG, mg/dl TG ≥ 150 mg/dl
OR (95% CI) c OR (95% CI) d
Q1 129.27 (92.09, 186.83) 1 1
Q2 142.56 (99.17, 204.54) 1.27 (1.08,1.49) 1.30 (1.10,1.54)
P = 4.34×10 −3 P = 1.89×10 −3
Q3 149.64 (107.14, 221.36) 1.49 (1.27,1.75) 1.51 (1.28,1.78)
P = 1.36×10 −6 P = 1.08×10 −6
Q4 147.87 (103.60, 223.13) 1.45 (1.22,1.73) 1.49 (1.25,1.77)
P = 2.10×10 −5 P = 1.03×10 −5
P a = 1.39×10 −12 P trend = 5.17×10 −8 P trend = 3.48×10 −8
P b = 1.71×10 −13

Abbreviations: BMI, body mass index; CI, confidence interval; OR, odds ratio; Q, quartile; TG, triglycerides. All non-Gaussian distributed quantitative traits were natural logarithmically transformed to normalize distributions.

a, P value calculated for genotype risk score for TG level using linear regression adjusted for age and sex.

b, P value calculated for genotype risk score for TG level using linear regression adjusted for age, sex, and BMI.

c, OR and 95% CI are reported for genotype risk score quartiles for a high TG level (≥ 150 mg/dl) using logistic regression adjusted for age and sex.

d, OR and 95% CI are reported for genotype risk score quartiles for a high TG level (≥ 150 mg/dl) using logistic regression adjusted for age, sex, and BMI.

P values <0.05 are shown in bold.